Remus Pharmaceuticals Ltd. Live Share Price Today, Share Analysis and Chart

Name: Remus Pharmaceuticals Ltd.: Is Infosys Ltd. worth buying?
Item: Remus Pharmaceuticals Ltd.
Rating: 1.28291675
Author: Trendlyne DVM scores

about

Remus Pharmaceuticals is engaged in the business of Marketing and distribution of API and Finished Formulations of Pharmaceutical drugs and Provision for Technical consultancy services in various countries including India.

811.25 -8.10 (-0.99%)

New 52W Low in past week

2,700

NSE Volume

NSE 17 Sep, 2025 3:31 PM (IST)

Dividend

Remus Pharmaceuticals Ltd. last dividend of ₹0.50 per share was given on 18 Sep 2025 See details

Loading... You have run out of DVM views! Check usage

Subscribe now to see details

Not Eligible

Expensive Valuation

22.2 / 100

Technically Bearish

29.2 / 100

No estimates available

Remus Pharma Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Remus Pharmaceuticals Ltd. Live Share Price Today, Share Analysis and Chart

Remus Pharmaceuticals is engaged in the business of Marketing and distribution of API and Finished Formulations of Pharmaceutical drugs and Provision for Technical consultancy services in various countries including India.

New 52W Low in past week

SWOT Analysis

Remus Pharma Live Price Chart